Pfizer And BioNTech Claim COVID-19 Vaccine Success

Interim Analysis Finds Vaccine 90% Effective, EUA Filing Expected Late November

 
• By Andrew McConaghie
  
Pfizer
Pfizer and BioNTech have produced better than expected efficacy results - but will wait for safety data before filing later this month.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip